ArticleBMC urology2024
Non-contrast CT attenuation value of renal papilla is a novel predictor of recurrence in kidney stone disease.
Article in BMC urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In calcium stone formers, most stones grow attached to Randall's plaque, which can be identified by measuring the computed tomography (CT) attenuation value of renal papilla. We hypothesized that the CT attenuation value of renal papilla can predict the severity (recurrent or multiple stone former) and recurrence of the stone disease. We retrospectively reviewed the charts of 180 calcium oxalate stone formers who underwent non-contrast CT and 24-hour urine chemistry in our hospital between September 2012 and November 2021. Two observers independently measured the Hounsfield unit (HU) of the renal papilla and classified the patients into the low-HU and the high-HU value groups according to the median value (38.9 HU). The proportion of recurrent and multiple stone formers were similar between the low-HU group and the high-HU group (70.0% vs. 65.6%, 71.1% vs. 74.2%, respectively). There were also no significant differences in urinary volume, urinary excretions of each constituent, or AP(CaOx) index between the two groups. On the other hand, the recurrence rate in the high-HU value group (0.10 events/person/year) was significantly higher than that in the low-HU value group (0 events/person/year, p = 0.03). Multivariate analysis revealed that high-HU value was an independent predictor of stone recurrence (OR 1.90, 95% CI 1.00-3.64, p = 0.04) as well as medical prophylaxis. The results of this study suggest that HU value of renal papilla is a useful predictor of recurrence of stone disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.